SRPT
NASDAQ · Biotechnology
Sarepta Therapeutics Inc
$21.49
+0.61 (+2.92%)
Open$20.93
Previous Close$20.88
Day High$21.66
Day Low$20.92
52W High$44.14
52W Low$10.42
Volume—
Avg Volume2.78M
Market Cap2.12B
P/E Ratio—
EPS$-7.24
SectorBiotechnology
Analyst Ratings
Hold
33 analysts
Price Target
+85.2% upside
Current
$21.49
$21.49
Target
$39.80
$39.80
$34.71
$39.80 avg
$61.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.17B | 1.63B | 549.72M |
| Net Income | -704,149,768 | -476,241,670 | -107,586,925 |
| Profit Margin | -32.5% | -30.8% | -19.6% |
| EBITDA | -667,536,549 | -476,560,999 | -125,300,242 |
| Free Cash Flow | — | — | -79,607,758 |
| Rev Growth | +33.1% | +33.1% | +15.5% |
| Debt/Equity | 0.73 | 0.73 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |